A F Klassen1, J N Newton, E Mallon. 1. Centre for Community Health and Health Evaluation Research, University of British Columbia, Vancouver, Canada.
Abstract
OBJECTIVE: Our purpose was to compare 3 approaches to the measurement of quality of life in patients referred for specialist care of acne. METHODS: A questionnaire was sent to 130 patients referred for management of their acne. Follow-up questionnaires were sent 4 and 12 months after treatment began. The questionnaire contained a generic index measure (EuroQol EQ-5D), a generic profile measure (Short Form 36), and a disease-specific measure (Dermatology Life Quality Index). Pretreatment results for the EQ-5D were compared with normative data. The responsiveness of the EQ-5D was compared with that of the other measures. RESULTS: Before treatment, the sample reported substantially more pain/discomfort and anxiety/depression on the EQ-5D compared with a population sample. The disease-specific measure was more responsive to change compared with both generic measures. CONCLUSION: Our study highlights the importance of combining information from generic measures with information from instruments designed specifically for use in people with skin disease.
OBJECTIVE: Our purpose was to compare 3 approaches to the measurement of quality of life in patients referred for specialist care of acne. METHODS: A questionnaire was sent to 130 patients referred for management of their acne. Follow-up questionnaires were sent 4 and 12 months after treatment began. The questionnaire contained a generic index measure (EuroQol EQ-5D), a generic profile measure (Short Form 36), and a disease-specific measure (Dermatology Life Quality Index). Pretreatment results for the EQ-5D were compared with normative data. The responsiveness of the EQ-5D was compared with that of the other measures. RESULTS: Before treatment, the sample reported substantially more pain/discomfort and anxiety/depression on the EQ-5D compared with a population sample. The disease-specific measure was more responsive to change compared with both generic measures. CONCLUSION: Our study highlights the importance of combining information from generic measures with information from instruments designed specifically for use in people with skin disease.
Authors: Diane M Thiboutot; Leon Kircik; Amy McMichael; Fran E Cook-Bolden; Stephen K Tyring; David R Berk; Joan-En Chang-Lin; Vince Lin; Alexandre Kaoukhov Journal: J Clin Aesthet Dermatol Date: 2016-10-01
Authors: M Kamphuis; K H Zwinderman; T Vogels; H W Vliegen; R P Kamphuis; J Ottenkamp; S P Verloove-Vanhorick; J Bruil Journal: Qual Life Res Date: 2004-05 Impact factor: 4.147
Authors: Perihan Oztürk; Fatma Özlem Orhan; Ali Ozer; Tuğba Karakaş; Ali Nuri Oksüz; Nur Yalçın Yetişir Journal: Balkan Med J Date: 2013-06-01 Impact factor: 2.021
Authors: Jean-Eric Tarride; Natasha Burke; Matthias Bischof; Robert B Hopkins; Linda Goeree; Kaitryn Campbell; Feng Xie; Daria O'Reilly; Ron Goeree Journal: Health Qual Life Outcomes Date: 2010-01-27 Impact factor: 3.186
Authors: Ilknur K Altunay; Ezgi Özkur; Florence J Dalgard; Uwe Gieler; Lucía Tomas Aragones; Lars Lien; Françoise Poot; Gregor B Jemec; Laurent Misery; Csanád Szabó; Dennis Linder; Francesca Sampogna; Andrea W M Evers; Jon Anders Halvorsen; Flora Balieva; Jacek C Szepietowski; Dmitry V Romanov; Servando E Marron; Andrew Y Finlay; Sam Salek; Jörg Kupfer Journal: Acta Derm Venereol Date: 2020-02-05 Impact factor: 3.875